Bifogade filer
PDF
Kurs
+1,74%
Likviditet
0,40 MNOK
Kalender
| Est. tid* | ||
| 2026-02-19 | 08:00 | Bokslutskommuniké 2025 |
| 2025-11-06 | 08:00 | Kvartalsrapport 2025-Q3 |
| 2025-08-26 | 08:00 | Kvartalsrapport 2025-Q2 |
| 2025-05-14 | N/A | X-dag ordinarie utdelning CONTX 0.00 NOK |
| 2025-05-13 | N/A | Årsstämma |
| 2025-05-07 | - | Kvartalsrapport 2025-Q1 |
| 2025-02-20 | - | Bokslutskommuniké 2024 |
| 2024-11-20 | - | Extra Bolagsstämma 2024 |
| 2024-11-07 | - | Kvartalsrapport 2024-Q3 |
| 2024-08-26 | - | Kvartalsrapport 2024-Q2 |
| 2024-05-15 | - | X-dag ordinarie utdelning CONTX 0.00 NOK |
| 2024-05-14 | - | Årsstämma |
| 2024-05-08 | - | Kvartalsrapport 2024-Q1 |
| 2024-02-15 | - | Bokslutskommuniké 2023 |
| 2023-11-02 | - | X-dag halvårsutdelning CONTX 0.15741 |
| 2023-10-26 | - | Kvartalsrapport 2023-Q3 |
| 2023-08-24 | - | Kvartalsrapport 2023-Q2 |
| 2023-05-08 | - | X-dag halvårsutdelning CONTX 0.15741 |
| 2023-05-03 | - | Årsstämma |
| 2023-04-27 | - | Kvartalsrapport 2023-Q1 |
| 2023-02-16 | - | Bokslutskommuniké 2022 |
| 2022-10-20 | - | Kvartalsrapport 2022-Q3 |
| 2022-08-11 | - | Kvartalsrapport 2022-Q2 |
| 2022-05-05 | - | X-dag ordinarie utdelning CONTX 0.00 NOK |
| 2022-05-04 | - | Årsstämma |
| 2022-04-21 | - | Kvartalsrapport 2022-Q1 |
| 2022-02-17 | - | Bokslutskommuniké 2021 |
| 2021-12-10 | - | Extra Bolagsstämma 2021 |
| 2021-10-21 | - | Kvartalsrapport 2021-Q3 |
| 2021-08-12 | - | Kvartalsrapport 2021-Q2 |
| 2021-05-06 | - | X-dag ordinarie utdelning CONTX 0.00 NOK |
| 2021-05-05 | - | Årsstämma |
| 2021-04-22 | - | Kvartalsrapport 2021-Q1 |
| 2021-02-18 | - | Bokslutskommuniké 2020 |
| 2020-10-22 | - | Kvartalsrapport 2020-Q3 |
| 2020-08-19 | - | Split CONTX 1:10 |
| 2020-08-13 | - | Kvartalsrapport 2020-Q2 |
| 2020-08-05 | - | Extra Bolagsstämma 2020 |
| 2020-05-07 | - | X-dag ordinarie utdelning CONTX 0.00 NOK |
| 2020-05-06 | - | Årsstämma |
| 2020-04-23 | - | Kvartalsrapport 2020-Q1 |
| 2020-02-20 | - | Bokslutskommuniké 2019 |
| 2019-10-24 | - | Kvartalsrapport 2019-Q3 |
| 2019-08-15 | - | Kvartalsrapport 2019-Q2 |
| 2019-05-09 | - | X-dag ordinarie utdelning CONTX 0.00 NOK |
| 2019-05-08 | - | Årsstämma |
| 2019-04-25 | - | Kvartalsrapport 2019-Q1 |
| 2019-02-21 | - | Bokslutskommuniké 2018 |
| 2018-10-25 | - | Kvartalsrapport 2018-Q3 |
| 2018-08-16 | - | Kvartalsrapport 2018-Q2 |
| 2018-05-11 | - | X-dag ordinarie utdelning CONTX 0.00 NOK |
| 2018-05-09 | - | Årsstämma |
| 2018-04-26 | - | Kvartalsrapport 2018-Q1 |
| 2018-02-22 | - | Bokslutskommuniké 2017 |
| 2017-10-26 | - | Kvartalsrapport 2017-Q3 |
| 2017-08-17 | - | Kvartalsrapport 2017-Q2 |
| 2017-05-11 | - | X-dag ordinarie utdelning CONTX 0.00 NOK |
| 2017-05-10 | - | Årsstämma |
| 2017-04-27 | - | Kvartalsrapport 2017-Q1 |
| 2017-02-23 | - | Bokslutskommuniké 2016 |
| 2016-10-27 | - | Kvartalsrapport 2016-Q3 |
| 2016-08-18 | - | Kvartalsrapport 2016-Q2 |
| 2016-04-21 | - | X-dag ordinarie utdelning CONTX 0.00 NOK |
| 2016-04-21 | - | Kvartalsrapport 2016-Q1 |
| 2016-04-20 | - | Årsstämma |
| 2016-02-18 | - | Bokslutskommuniké 2015 |
| 2015-10-22 | - | Kvartalsrapport 2015-Q3 |
| 2015-08-20 | - | Kvartalsrapport 2015-Q2 |
| 2015-04-23 | - | X-dag ordinarie utdelning CONTX 0.00 NOK |
| 2015-04-23 | - | Kvartalsrapport 2015-Q1 |
| 2015-04-22 | - | Årsstämma |
| 2015-02-19 | - | Bokslutskommuniké 2014 |
| 2014-10-23 | - | Kvartalsrapport 2014-Q3 |
| 2014-08-21 | - | Kvartalsrapport 2014-Q2 |
| 2014-05-12 | - | 15-7 2014 |
| 2014-04-24 | - | X-dag ordinarie utdelning CONTX 0.00 NOK |
| 2014-04-24 | - | Kvartalsrapport 2014-Q1 |
| 2014-04-23 | - | Årsstämma |
| 2014-02-20 | - | Bokslutskommuniké 2013 |
| 2013-10-24 | - | Kvartalsrapport 2013-Q3 |
| 2013-08-22 | - | Kvartalsrapport 2013-Q2 |
| 2013-06-13 | - | X-dag ordinarie utdelning CONTX 0.00 NOK |
| 2013-06-12 | - | Årsstämma |
| 2013-04-25 | - | Kvartalsrapport 2013-Q1 |
| 2013-02-21 | - | Bokslutskommuniké 2012 |
| 2012-10-25 | - | Kvartalsrapport 2012-Q3 |
| 2012-08-23 | - | Kvartalsrapport 2012-Q2 |
| 2012-06-14 | - | X-dag ordinarie utdelning CONTX 0.00 NOK |
| 2012-06-13 | - | Årsstämma |
| 2012-04-26 | - | Kvartalsrapport 2012-Q1 |
| 2012-02-23 | - | Bokslutskommuniké 2011 |
| 2011-10-27 | - | Kvartalsrapport 2011-Q3 |
| 2011-08-25 | - | Kvartalsrapport 2011-Q2 |
| 2011-06-10 | - | X-dag ordinarie utdelning CONTX 0.00 NOK |
| 2011-06-09 | - | Årsstämma |
| 2011-04-28 | - | Kvartalsrapport 2011-Q1 |
| 2011-02-17 | - | Bokslutskommuniké 2010 |
| 2010-10-21 | - | Kvartalsrapport 2010-Q3 |
| 2010-08-19 | - | Kvartalsrapport 2010-Q2 |
| 2010-06-04 | - | X-dag ordinarie utdelning CONTX 0.00 NOK |
| 2010-06-03 | - | Årsstämma |
| 2010-04-21 | - | Kvartalsrapport 2010-Q1 |
| 2010-02-18 | - | Bokslutskommuniké 2009 |
| 2009-10-22 | - | Kvartalsrapport 2009-Q3 |
| 2009-08-20 | - | Kvartalsrapport 2009-Q2 |
| 2009-04-23 | - | Kvartalsrapport 2009-Q1 |
| 2008-06-06 | - | X-dag ordinarie utdelning CONTX 1.50 NOK |
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Oslo Bors |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
STOCKHOLM - April 21, 2022 - ContextVision, a medical technology software company specializing in image processing and image analysis, today reports its first quarter results for 2022.
The quarter saw a very strong progress with a revenue of 27,2MSEK (20,3) and an EBITDA of 9,2MSEK (9,8).
"It has been an exciting quarter where we have been able to establish the new organization and fully focus on Medical Imaging business. During the quarter we signed both new customers as well as extended several current customers to include our state-of-the-art products Altumira and Rivent" - Ola Lindblad, acting CEO of ContextVision.
"We see strong demand"
Because of an increased demand from the overall market, we have released two new ultrasound products to extend the Rivent product family. A new 3D solution and a mobile solution aimed at the fast-growing handheld market. The feedback so far from the market has been very positive.
"With the shift in focus, the strong financials and the solid customer base we are off to a great start. We see strong demand going forward and we are looking forward to the rest of the year" - says Lindblad.
"Will give us a boost"
As of February 2022, the de-merger of Infiy Laboratories was finalized, which enables ContextVision to fully focus on the Company's core business, a world leading medical imaging technology.
"Being able to focus 100 percent on our core business will give us a boost. I already see the results in this first quarter" - says Lindblad.
For further information, please contact ContextVision's acting CEO, Ola Lindblad, at +46 8 750 35 50 or ola.lindblad@contextvision.seor visit www.contextvision.com (https://www.globenewswire.com/Tracker?data=3MaQGqfStsB_Z2n6YL96mk-0dfygLw6oN4eKvMWXKupICwsDDzA5ube1toUXebPYzar4qnu3TeaXF33IVlLZ60EyMCEFEOWZap0EhVSqE-zUKei2pFNr5cBFltRYMNo6kn7oL7CJxcgVx-hYON67FOGIkP2rl4-54NJMeD5MzrIVSQFWmgmZB085ANCWw_-3WhU_QFycYwSw79n9hRO8bD7Hmgptb56Phn4abKPm1hKO_3dkThorqVpb9FHkE5KXb2U2zArc9gueaSXiPxhqyw==).